Freedman Financial Associates, Inc. Amgen Inc Transaction History

Freedman Financial Associates, Inc.

  • $0
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$230.71 - $256.74 $80,517 - $89,602
-349 Closed
0 $0
Q1 2022

Apr 13, 2022
BUY
$219.27 - $242.57 $5,262 - $5,821
24 Added 7.38%
349 $85,000
Q4 2020

Feb 17, 2021
BUY
$216.38 - $257.67 $70,323 - $83,742
325 New
325 $75,000

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Freedman Financial Associates, Inc. Portfolio

Follow Freedman Financial Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freedman Financial Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Freedman Financial Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email